News: Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

11.48EUR
11:35am EDT
Price Change (% chg)

€-0.14 (-1.20%)
Prev Close
€11.62
Open
€11.52
Day's High
€11.63
Day's Low
€11.28
Volume
182,990
Avg. Vol
237,813
52-wk High
€13.03
52-wk Low
€9.38

Search Stocks
Select another date:

Thu, Sep 25 2014

EU agency backs Almirall lung drug being bought by AstraZeneca

LONDON - A combination drug for chronic lung disease from Spain's Almirall, one of a number of respiratory medicines being acquired by AstraZeneca, has been recommended for approval by European regulators.

EU agency backs Almirall lung drug being bought by AstraZeneca

LONDON, Sept 25 - A combination drug for chronic lung disease from Spain's Almirall, one of a number of respiratory medicines being acquired by AstraZeneca, has been recommended for approval by European regulators.

Almirall says in deal with Astrazeneca over respiratory business

MADRID, July 30 - Spain's Almirall on Wednesday said it had reached a deal to transfer to Astrazeneca the rights of its respiratory franchise for an initial $875 million. (Reporting by Julien Toyer; Editing by Tracy Rucinski)

AstraZeneca boosts lung drug business with up to $2.1 bln Almirall deal

LONDON, July 30 - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

Select another date:

Press Releases

Search Stocks